The Merck Group, which is headquartered in Darmstadt, Germany, is a global corporate group. With a history dating back nearly 350 years, it is the world’s oldest pharmaceutical and chemical company. Merck holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where Merck operates as EMD. Merck’s product portfolio ranges from innovative pharmaceuticals and biopharmaceutical products, to specialty chemicals, high-tech materials and life science tools. Merck markets its wide range of products within its four divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. Merck Group | Sales [...]
[...] 17.3 Merck Millipore 658.7 4.0 –4.2 –0.9 –1.1 Merck Group 2,795.5 3.4 –4.5 3.0 1.9 All four divisions of the Merck Group posted organic sales increases as well as negative exchange rate effects in the second quarter of 2014. Delivering an absolute increase of € 44 million, which corresponded to an organic growth rate of 3.0%, Merck Serono made the strongest absolute contribution to organic sales growth, followed by Merck Millipore with organic sales growth of € 27 million equivalent to a growth rate of 4.0%, and Consumer Health with organic sales growth of € 15 million or 8.5%. The Performance Materials division achieved an organic sales growth rate [...]
XLS Merck Serono | Key figures € million Q2 – 2014 Q2 – 20131 Change in % Jan.–June 2014 Jan.–June 20131 Change in % 1 The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 1,510.7 1,560.5 –3.2 2,931.8 3,042.6 –3.6 Sales 1,446.4 1,467.6 –1.4 2,821.3 2,856.3 –1.2 Operating result (EBIT) 239.7 266.4 –10.0 475.5 436.6 8.9 Margin (% of sales) 16.6 18.2 16.9 15.3 EBITDA 444.3 477.7 –7.0 872.3 886.0 –1.6 Margin (% of sales) 30.7 32.6 30.9 31.0 EBITDA pre one-time items 452.0 474.8 –4.8 890.1 912.5 –2.5 Margin (% of sales) 31.3 32.4 31.5 31.9 Business free cash flow 337.3 485.7 –30.6 [...]
XLS Consumer Health | Key figures € million Q2 – 2014 Q2 – 20131 Change in % Jan.–June 2014 Jan.–June 20131 Change in % 1 The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 185.0 180.1 2.7 365.6 361.9 1.0 Sales 184.7 178.9 3.3 364.9 360.6 1.2 Operating result (EBIT) 36.9 34.2 7.9 73.7 71.0 3.8 Margin (% of sales) 20.0 19.1 20.2 19.7 EBITDA 39.3 36.5 7.6 78.4 76.0 3.3 Margin (% of sales) 21.3 20.4 21.5 21.1 EBITDA pre one-time items 41.4 35.5 16.7 82.6 74.8 10.5 Margin (% of sales) 22.4 19.8 22.6 20.7 Business free cash flow 36.2 50.9 –28.9 52.4 71.8 –27.0 Development of sales and results of [...]
[...] organization and reporting structure of the Merck Group. The fields of activity of the individual divisions are described in detail in the sections about the divisions in the interim management report. The column “Corporate and Other” includes assets and liabilities as well as income and expenses that cannot be directly allocated to the reportable segments. These mainly relate to Group functions. Moreover, the column serves the reconciliation to the Group numbers. The cash flows from the financial result and income taxes are also disclosed under “Corporate and Other”. Apart from sales, the success of a segment is mainly determined by EBITDA pre one-time [...]
